Woolley D E
Cancer Metastasis Rev. 1984;3(4):361-72. doi: 10.1007/BF00051460.
Connective tissue stroma and basement membrane structures probably present natural barriers to the migration of tumor cells. It has therefore been proposed that collagenolytic enzymes are required to facilitate the spread and invasion of tumor cells into host tissues. The collagenases and cathepsin B-like enzymes are thought to be involved, but the cellular source of collagenolytic activity at the tumor: host interface or 'invasion zone' remains obscure in most cases. The 'invasion zone' of different tumors is very variable with regard to the type and numbers of host or tumor cells, as well as the type of collagenous matrix, and few generalities can be made. The existence within a tumor of specialised subpopulations of cells which have different metastatic potential has been postulated. As a consequence it seems plausible that the phenotypic expression of highly invasive or metastatic tumor cells should include the potential for generating collagenolytic activity. Immunolocalisation studies have demonstrated the production of type I and type IV collagenases at sites of tumor invasion, but it does not appear to be a continuous process and only a small proportion of tumor and/or host cells elaborate enzyme at any one moment. Collagenase production is invariably microenvironmental in nature and it seems likely that local host:tumor cell interactions are important in modulating collagenolysis. Macrophages and mast cells have been shown to stimulate collagenase expression by tumor and stromal cells in vitro, and it is proposed that these cells may assume a contributory role for the induction of collagenolytic activity in vivo. The collagenolytic mechanisms that operate at micro-foci of host:tumor junctions probably depend upon the type of collagen, the cellular composition and the extracellular ionic conditions of each invasion site. Either tumor or host cells may elaborate enzymes, this being dependent upon the type and/or tissue location of the invasive tumor.
结缔组织基质和基底膜结构可能是肿瘤细胞迁移的天然屏障。因此,有人提出需要胶原溶解酶来促进肿瘤细胞向宿主组织的扩散和侵袭。胶原酶和组织蛋白酶B样酶被认为与之有关,但在大多数情况下,肿瘤与宿主界面或“侵袭区”胶原溶解活性的细胞来源仍不清楚。不同肿瘤的“侵袭区”在宿主或肿瘤细胞的类型和数量以及胶原基质的类型方面差异很大,几乎没有什么共性可言。有人推测肿瘤内存在具有不同转移潜能的特殊细胞亚群。因此,高度侵袭性或转移性肿瘤细胞的表型表达应该包括产生胶原溶解活性的潜能,这似乎是合理的。免疫定位研究已经证明在肿瘤侵袭部位产生了I型和IV型胶原酶,但这似乎不是一个连续的过程,在任何时刻只有一小部分肿瘤和/或宿主细胞能产生这种酶。胶原酶的产生本质上总是受微环境影响的,局部宿主与肿瘤细胞的相互作用在调节胶原溶解过程中可能很重要。巨噬细胞和肥大细胞在体外已被证明能刺激肿瘤和基质细胞表达胶原酶,有人提出这些细胞可能在体内诱导胶原溶解活性中起辅助作用。在宿主与肿瘤交界处的微灶处起作用的胶原溶解机制可能取决于每个侵袭部位的胶原类型、细胞组成和细胞外离子条件。肿瘤或宿主细胞都可能产生酶,这取决于侵袭性肿瘤的类型和/或组织位置。